AGTC Selected to the University of Florida’s 2016 Gator100


Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that the company has been selected to the 2016 Gator100.

The Gator100, named after the University of Florida’s mascot, annually recognizes and celebrates the 100 fastest-growing businesses in the world that are either owned or led by University of Florida graduates. It is sponsored by the University‘s Entrepreneurship & Innovation Center and Warrington College of Business. The winning companies were announced earlier today at the Gator100 Awards Gala at the University of Florida.